Immediate Impact
54 standout
Citing Papers
Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapy
2025 Standout
Precision nanomedicine: navigating the tumor microenvironment for enhanced cancer immunotherapy and targeted drug delivery
2025 Standout
Works of Riyad A. Almaimani being referenced
Paclitaxel and naringenin-loaded solid lipid nanoparticles surface modified with cyclic peptides with improved tumor targeting ability in glioblastoma multiforme
2021
Tamoxifen and the PI3K Inhibitor: LY294002 Synergistically Induce Apoptosis and Cell Cycle Arrest in Breast Cancer MCF-7 Cells
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Riyad A. Almaimani | 195 | 100 | 88 | 98 | 51 | 682 | |
| Kyeong Seok Kim | 233 | 98 | 53 | 75 | 32 | 739 | |
| Mazen M. Ghaith | 122 | 61 | 146 | 67 | 32 | 624 | |
| P. C. Sen Gupta | 272 | 70 | 63 | 75 | 45 | 740 | |
| Xueting Mei | 250 | 62 | 73 | 99 | 35 | 822 | |
| Kafil Akhtar | 176 | 97 | 72 | 105 | 89 | 839 | |
| Nadia Z. Shaban | 163 | 50 | 144 | 48 | 36 | 685 | |
| Melanie Esselen | 289 | 62 | 49 | 52 | 49 | 816 | |
| Hany Elsawy | 184 | 58 | 53 | 144 | 47 | 812 | |
| Mojtaba Kalantar | 142 | 159 | 52 | 82 | 54 | 752 | |
| Abhishek Basu | 223 | 106 | 256 | 103 | 41 | 803 |
All Works
Login with ORCID to disown or claim papers
Loading papers...